华润三九,000999,收入构成,报告日期,2020-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 印刷包装分部,31039,23767,7271,23.43%,1.99% 医药行业分部,562240,204827,357413,63.57%,98.03% 其他,11,-- ,-- ,--,0% 分部间相互抵减,-10048,-9941,-107,1.07%,-0.03% 华润三九,000999,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),-- ,36460,-- ,--,0% 其他,2199,-- ,-- ,--,0% 医药行业-处方药,659023,131365,527658,80.07%,54.2% 海外贸易,3909,-- ,-- ,--,0% 医药行业-自我诊疗(CHC),755564,309690,445874,59.01%,45.8% 包装印刷,49497,-- ,-- ,--,0% 华润三九,000999,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其中:处方药,310157,70610,239547,77.23%,25.51% 医药行业分部,692807,228698,464109,66.99%,49.43% 印刷包装分部,34226,25222,9004,26.31%,0.96% 分部间相互抵减,-10363,-10662,300,-2.89%,0.03% 其中:自我诊疗(CHC),369529,143566,225963,61.15%,24.07% 其他,11,-- ,-- ,--,0% 华润三九,000999,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药行业-处方药,619615,106553,513062,82.8%,55.99% 医药行业-自我诊疗,666521,263213,403308,60.51%,44.01% 其他,2679,-- ,-- ,--,0% 包装印刷,49858,-- ,-- ,--,0% 海外贸易,4102,-- ,-- ,--,0% 华润三九,000999,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 分部间相互抵减,-10157,-10050,-107,1.06%,-0.02% 其他,9,56,-46,-486.29%,-0.01% 医药行业分部,622633,191759,430874,69.2%,98.73% 印刷包装分部,34725,29041,5684,16.37%,1.3% 华润三九,000999,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,2088,-- ,-- ,--,0% 海外贸易,2693,-- ,-- ,--,0% 包装印刷,46903,-- ,-- ,--,0% 医药行业-处方药,517375,124807,392569,75.88%,55.17% 医药行业-自我诊疗,542933,224002,318931,58.74%,44.83% 华润三九,000999,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其中:处方药,201516,58715,142801,70.86%,23.3% 其中:自我诊疗,271632,107947,163686,60.26%,26.7% 医药行业,473148,166661,306487,64.78%,50% 华润三九,000999,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药行业-处方药,379507,103919,275588,72.62%,49.99% 其他(补充),2526,1701,825,32.65%,0.15% 海外贸易,1848,-- ,-- ,--,0% 包装印刷,45346,-- ,-- ,--,0% 医药行业-自我诊疗,468945,194101,274844,58.61%,49.86% 华润三九,000999,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药行业-处方药,168135,48790,119345,70.98%,44.49% 其他,1672,1455,217,13%,0.08% 海外贸易,227,151,76,33.65%,0.03% 包装印刷,20934,14786,6149,29.37%,2.29% 医药行业-自我诊疗,237104,94628,142476,60.09%,53.11% 华润三九,000999,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药行业-处方药,303670,101421,202248,66.6%,42.93% 其他,4914,-- ,-- ,--,0% 海外贸易,3461,-- ,-- ,--,0% 包装印刷,39934,-- ,-- ,--,0% 医药行业-自我诊疗,438041,169193,268848,61.38%,57.07% 华润三九,000999,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 海外贸易,917,705,211,23.05%,0.05% 其中:自我诊疗,210693,77140,133552,63.39%,29.78% 其他,2076,578,1498,72.15%,0.33% 其中:处方药,135618,48251,87367,64.42%,19.48% 其他(补充),878,324,554,63.12%,0.12% 包装印刷,19388,15061,4327,22.32%,0.96% 医药行业,346311,125391,220919,63.79%,49.27% 华润三九,000999,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,2887,768,2119,73.4%,0.24% 其中:处方药,270466,87623,182843,67.6%,20.75% 海外贸易,3384,2577,807,23.86%,0.09% 其中:非处方药,408110,156163,251946,61.73%,28.59% 其他(补充),2540,1850,689,27.14%,0.08% 包装印刷,40273,32237,8036,19.95%,0.91% 医药行业,678575,243786,434789,64.07%,49.34% 华润三九,000999,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2998,-- ,-- ,--,0% 其他,2936,767,2169,73.88%,0.97% 海外贸易,2184,1561,622,28.51%,0.28% 医疗服务,31650,23638,8012,25.32%,3.59% 包装印刷,20202,15099,5103,25.26%,2.29% 处方药,127980,44922,83059,64.9%,37.22% 非处方药,193930,69731,124199,64.04%,55.65% 华润三九,000999,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),4437,-- ,-- ,--,0% 其他,452,259,194,42.86%,0.04% 海外贸易,4890,3518,1371,28.05%,0.29% 医疗服务,49975,38272,11703,23.42%,2.49% 包装印刷,43742,30885,12857,29.39%,2.74% 处方药,264958,80066,184892,69.78%,39.4% 非处方药,411707,153485,258223,62.72%,55.03% 华润三九,000999,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1164,684,480,41.2%,0.2% 其他,121,68,53,43.99%,0.02% 海外贸易,1981,1347,635,32.04%,0.27% 医疗服务,22090,16970,5120,23.18%,2.17% 包装印刷,21018,14866,6152,29.27%,2.61% 处方药,126571,37737,88834,70.19%,37.69% 非处方药,207104,72696,134408,64.9%,57.03% 华润三九,000999,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2222,1070,1153,51.87%,0.27% 其他,248,332,-84,-33.64%,-0.02% 海外贸易,4623,3294,1329,28.75%,0.32% 医疗服务,39309,29800,9509,24.19%,2.26% 包装印刷,43286,30353,12933,29.88%,3.07% 处方药,229545,77063,152482,66.43%,36.19% 非处方药,369876,125910,243966,65.96%,57.91% 华润三九,000999,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,13,13,-0,-1.03%,-0% 包装印刷,21230,16189,5041,23.74%,1.32% 医疗服务,18111,13626,4485,24.76%,1.17% 医药行业,287547,101947,185600,64.55%,48.6% 海外贸易,2618,1915,703,26.84%,0.18% 其中:处方药,109439,37582,71857,65.66%,18.81% 其他(补充),976,474,502,51.47%,0.13% 其中:OTC,178108,64365,113743,63.86%,29.78% 华润三九,000999,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1876,802,1073,57.22%,0.33% 其他,3078,777,2300,74.74%,0.71% 海外贸易,6894,5466,1428,20.71%,0.44% 医疗服务,29425,22067,7358,25.01%,2.26% 包装印刷,41092,29295,11797,28.71%,3.62% 处方药,152482,51020,101462,66.54%,31.14% OTC,317677,117312,200365,63.07%,61.5% 华润三九,000999,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),940,497,443,47.1%,0.3% 海外贸易,2680,1993,687,25.65%,0.47% 房地产,2938,791,2147,73.07%,1.48% 医疗服务,12137,9011,3126,25.76%,2.15% 包装印刷,18510,13032,5477,29.59%,3.77% 处方药,59224,19193,40031,67.59%,27.57% OTC,148831,55519,93313,62.7%,64.25% 华润三九,000999,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 海外贸易,7019,4900,2119,30.19%,0.79% 房地产,1367,1018,350,25.57%,0.13% 医疗服务,20317,15132,5184,25.52%,1.94% 包装印刷,34349,23618,10731,31.24%,4.02% 中药配方颗粒,29803,12112,17691,59.36%,6.63% 中药处方药,55039,16108,38930,70.73%,14.6% 抗生素及原料药,32045,12546,19498,60.85%,7.31% OTC,254373,82202,172171,67.68%,64.56% 华润三九,000999,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 房地产,219,190,28,13.02%,0.02% 医疗服务,8335,5952,2383,28.59%,1.96% 包装印刷,16306,12318,3988,24.45%,3.27% 药品批发,3482,2367,1115,32.02%,0.92% 中药配方颗粒,13526,5640,7886,58.3%,6.47% 中药处方药,25833,4809,21024,81.39%,17.26% 抗生素及原料药,13437,6470,6967,51.85%,5.72% OTC,115718,37289,78429,67.78%,64.38% 华润三九,000999,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 食品行业,15902,9553,6349,39.93%,2.61% 房地产,2037,2730,-693,-34.05%,-0.28% 医疗服务,15927,11572,4356,27.35%,1.79% 包装印刷,31173,22703,8470,27.17%,3.48% 药品批发零售,102680,93054,9626,9.38%,3.95% 中药配方颗粒,21346,8384,12962,60.72%,5.33% 中药处方药,41887,8439,33447,79.85%,13.74% 抗生素及原料药,26095,13581,12513,47.95%,5.14% OTC,225654,69270,156384,69.3%,64.25% 华润三九,000999,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 皮炎平软膏,26642,9530,17112,64.23%,45.02% 感冒灵系列,37035,16132,20902,56.44%,54.98% 华润三九,000999,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 感冒灵系列,70422,30493,39929,56.7%,100% 华润三九,000999,收入构成,报告日期,2008-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 感冒灵系列,26528,11537,14991,56.51%,-30.99% 皮炎平软膏,24660,88019,-63359,-256.93%,130.99% 华润三九,000999,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 感冒药系列,61421,25305,36116,58.8%,61.81% 皮炎平软膏,34393,12079,22314,64.88%,38.19% 华润三九,000999,收入构成,报告日期,2007-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 感冒灵,21086,8411,12675,60.11%,46.36% 皮炎平,21901,7238,14663,66.95%,53.64% 华润三九,000999,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 感冒灵,48259,19921,28338,58.72%,51.74% 皮炎平软膏,40689,14262,26428,64.95%,48.26% 华润三九,000999,收入构成,报告日期,2006-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 感冒灵,27887,12178,15709,56.33%,45.25% 皮炎平软膏,28701,9698,19003,66.21%,54.75% 华润三九,000999,收入构成,报告日期,2006-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 皮炎平,5523,2014,3509,63.54%,29.91% 感冒灵,13967,5746,8221,58.86%,70.09% 华润三九,000999,收入构成,报告日期,2005-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 感冒灵,43749,17355,26394,60.33%,53.62% 皮炎平软膏,35518,12687,22831,64.28%,46.38% 华润三九,000999,收入构成,报告日期,2005-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 皮炎平软膏,24553,8766,15788,64.3%,49.02% 感冒灵,27879,11461,16418,58.89%,50.98% 华润三九,000999,收入构成,报告日期,2005-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 感冒灵,17940,7427,10513,58.6%,47.87% 皮炎平软膏,18014,6564,11449,63.56%,52.13% 华润三九,000999,收入构成,报告日期,2005-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 感冒灵,11023,4134,6889,62.5%,100% 华润三九,000999,收入构成,报告日期,2004-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 参附注射液,11159,4185,6974,62.5%,17.7% 感冒灵,20287,8494,11793,58.13%,29.93% 皮炎平软膏,32619,11984,20635,63.26%,52.37% 华润三九,000999,收入构成,报告日期,2004-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 感冒灵,11927,5093,6834,57.3%,33.57% 皮炎平软膏,20743,7219,13524,65.2%,66.43% 华润三九,000999,收入构成,报告日期,2003-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 感冒灵,28023,12574,15449,55.13%,40.53% 皮炎平软膏,37316,14643,22673,60.76%,59.47% 华润三九,000999,收入构成,报告日期,2003-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,508,342,167,32.75%,0.28% 医疗服务,1937,859,1078,55.64%,1.84% 调味品,1321,828,494,37.36%,0.84% 房地产,5120,3882,1237,24.17%,2.12% 包装印刷品,6377,3667,2710,42.49%,4.64% 中药材,6465,5005,1460,22.58%,2.5% 西药,30437,16806,13631,44.78%,23.32% 中成药,66174,28505,37669,56.92%,64.45%